by admin_prosemble | 20th November 2025 | News
Judy Kingswolf-Yamakawa attended the Women’s Innovation Showcase on 20 November as part of London Life Sciences Week. The event focused on women’s health, fertility, hormones, and emerging life science ventures. Prosemble represented our nanoparticle oncology research...
by admin_prosemble | 19th November 2025 | News
Prosemble is proud to announce that Inna Zhuranskaya and Dr. Ludovico Pipito were honoured at the MedX@Düsseldorf soirée with a prestigious award for their groundbreaking work in AI/ML platforms for drug discovery and protein nanoparticles for drug delivery. The award...
by admin_prosemble | 19th November 2025 | News
Judy Kingswolf-Yamakawa showcased Prosemble’s technology at the Bench to Business Forum, part of London Life Sciences Showcase. Her pitch was one of the most well-received of the day, sparking productive conversations with founders, academic groups, and investors from...
by admin_prosemble | 18th November 2025 | News
Prosemble is thrilled to share that Inna Zhuranskaya and Dr. Ludovico Pipito attended MEDICA 2025 after winning a coveted booth in the Start-Up Park, where we were recognised as one of the Top 20 Start-Ups in the World. Funded by the Office of Economic Development...
by admin_prosemble | 17th November 2025 | News
Prosemble kicked off London Life Sciences Week with a strong presence at the Cancer Tech Accelerator Innovators Forum. Judy Kingswolf-Yamakawa presented our advancements in protein nanoparticles and AI toxicity platforms, alongside leading oncology and ecosystem...
by admin_prosemble | 12th November 2025 | News
Prosemble’s Inna Zhuranskaya and Tamara Veres had the opportunity to attend the exclusive GP/LP event at Web Summit, organised by Geek VC. The focus of the event was on “Raising Capital from Institutional LPs in 2026: Dos and Don’ts,” and featured insights from...
